BOD
vs
S
S&P/ASX 300
BOD
Over the past 12 months, BOD has underperformed S&P/ASX 300, delivering a return of 0% compared to the S&P/ASX 300's +3% growth.
Stocks Performance
BOD vs S&P/ASX 300
Performance Gap
BOD vs S&P/ASX 300
Performance By Year
BOD vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
BOD Australia Ltd
Glance View
Bod Australia Ltd. operates as a developer, manufacturer, distributor, importer, exporter and marketer of skincare, beauty, and health industries for the natural segment of the market. The company is headquartered in Sydney, New South Wales. The company went IPO on 2016-10-27. The firm is engaged in the development and manufacture of cannabidiol (CBD) and hemp products for consumer markets in Australia and United Kingdom, as well as the development, manufacture and distribution of therapeutics medicinal cannabis products. The firm operates through three segments: medical, over the counter cannabidiol/Hemp (OTC CBD/Hemp) and OTC Herbals.
